Responses
Clinical and epidemiological research
Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study)
Compose a Response to This Article
Other responses
No responses have been published for this article.